Онкология SUNITINIB IN THE LONG-TERM TREATMENT OF THE PATIENT WITH CLEAR-CELLULAR METASTATIC RENAL CELL CARCINOMA IN THE SECOND-LINE THERAPY: A CASE REPORT
eng
ONCOLOGY BULLETIN OF THE VOLGA REGION

Scientific-practical Journal for general practitioners and researchers

Search

SUNITINIB IN THE LONG-TERM TREATMENT OF THE PATIENT WITH CLEAR-CELLULAR METASTATIC RENAL CELL CARCINOMA IN THE SECOND-LINE THERAPY: A CASE REPORT

E.N. Yakovleva 

Republican Oncology Clinic of the Ministry of Health of Republic of Chuvashia, Cheboksary

 

 

Yakovleva E.N. — deputy chief physician of the medical work

23 Gladkova St., Cheboksary, Russian Federation, 428000, tel. +7-903-358-96-62, e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра.

 

 

Abstract. We analyzed clinical case of the effective long-term treatment of the patient with metastatic renal cell carcinoma in the second-line therapy. Presents an analysis of the clinical efficacy and safety in sunitinib-treated patient.

Key words: clinical practice, metastatic renal cell carcinoma, sunitinib, bevacizumab.





Наши партнеры



Copyright © 2014 | Все права защищены
RAFANDOS.COM | SUPPORT